Generate Biomedicines, Inc. Common Stock GENB
Analyst Ratings
- Consensus
- Buy — 6 Buy · 0 Hold · 0 Sell (6 analysts)
- Avg. Price Target
- $25.40 (+57.4% upside)
Key Stats
- Today's Range
- $15.93 – $20.14
- 50-Day Range
- $12.49 – $22.67
- 52-Week Range
- $11.00 – $22.67
- Volume
- 3.85 million shs
- Average Volume
- 875K shs
- Market Cap
- $2.62 billion
- P/E Ratio
- —
- Dividend Yield
- —
Valuation
- P/E Ratio
- —
- Price / Book
- 5.74
- Price / Sales
- —
Short Interest
- Short Interest
- 0.70%
- Days to Cover
- 1.00
About Generate Biomedicines, Inc. Common Stock
Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company's single operating segment is engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics. Its product candidates include: GB-0895, GB-4362, and GB-5267. Through the company's Generate Platform, it can generate medicines on demand across multiple therapeutic modalities with unprecedented speed representing a fundamental shift in drug discovery.
Related Stocks
Compare head-to-head: GENB vs LLY·GENB vs JNJ·GENB vs ABBV·GENB vs ABT
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.